2019
DOI: 10.1016/j.ccr.2019.06.004
|View full text |Cite
|
Sign up to set email alerts
|

Ferrocene derivatives as anti-infective agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
59
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 101 publications
(65 citation statements)
references
References 260 publications
0
59
0
1
Order By: Relevance
“…Alternatively, many AMPs have been embellished with organometallic substituents including metallocenes, leading to improved activity [10–12] . Ferrocene in particular is inexpensive and known to display rather low toxicity (rat, oral LD 50 =1320 mg/kg); [13] accordingly, many ferrocene‐based antimicrobials have been reported and show improved efficacy as antimicrobial agents compared to their more traditional analogs [14–17] . In one example, synthetically derived ferrocene‐containing penems had superior anti‐MRSA activity, exhibiting as much as an approximately fourfold elevation, while also displaying a modest twofold enhancement in activity against Gram‐negative strains compared to their non‐organometallic antibiotic counterparts (Figure 1, left) [14,15] .…”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…Alternatively, many AMPs have been embellished with organometallic substituents including metallocenes, leading to improved activity [10–12] . Ferrocene in particular is inexpensive and known to display rather low toxicity (rat, oral LD 50 =1320 mg/kg); [13] accordingly, many ferrocene‐based antimicrobials have been reported and show improved efficacy as antimicrobial agents compared to their more traditional analogs [14–17] . In one example, synthetically derived ferrocene‐containing penems had superior anti‐MRSA activity, exhibiting as much as an approximately fourfold elevation, while also displaying a modest twofold enhancement in activity against Gram‐negative strains compared to their non‐organometallic antibiotic counterparts (Figure 1, left) [14,15] .…”
Section: Figurementioning
confidence: 99%
“…Ferrocene in particular is inexpensive and known to display rather low toxicity (rat, oral LD 50 =1320 mg/kg); [13] accordingly, many ferrocene‐based antimicrobials have been reported and show improved efficacy as antimicrobial agents compared to their more traditional analogs [14–17] . In one example, synthetically derived ferrocene‐containing penems had superior anti‐MRSA activity, exhibiting as much as an approximately fourfold elevation, while also displaying a modest twofold enhancement in activity against Gram‐negative strains compared to their non‐organometallic antibiotic counterparts (Figure 1, left) [14,15] . For other small molecule antibiotic mimics, the incorporation of ferrocene with dithiothione and dithioketone moieties resulted in good activity against both Escherichia coli and Streptococcus pyogenes (MIC=10 μg/mL; Figure 1, center) [16] .…”
Section: Figurementioning
confidence: 99%
“…The drugs mentioned above were reported to exhibit improved therapeutic effects compared to their parent drugs. Ferroquine has reached the clinical trial phase (II), and ferrocifen is currently in a preclinical trial [24–26] . There are several research reports on ferrocene‐based compounds with various biological activities (Figure 1).…”
Section: Introductionmentioning
confidence: 99%
“…Since their discovery ferrocene (Fc) and its derivatives have been proved to be the excellent chemical reagents in organic and organometallic synthesis, electrochemistry, catalysts, and design of new chiral materials . Nowadays, they have wide applications, for example, medicine, electro‐optical devices, modified electrodes and capacitors, biosensors, and protective coating materials …”
Section: Introductionmentioning
confidence: 99%